Donations that make a difference
Direct funding or sponsorship of research is an easy and effective way to support CCIA. Here are a few of the ways your generosity can contribute to finding a cure for childhood cancer:
• Purchase or donate a specific piece of research equipment with your company’s name on it – see our “Scientist’s shopping list”. Once the equipment is installed, your team can visit the CCIA research lab to see their donation in use and understand the job it does.
• Funding for our scientists, ranging from top-up salaries for talented young PhD students through to a named research fellow. Your team can meet your funded researcher and hear about the fantastic work they are doing in the fight against cancer.
• Multi-year pledges to support a specific piece of research with defined outcomes and milestones. You will receive regular updates on the progress of the funded program and meet the team behind it.
• Sponsorship of a CCIA project or fundraising event. You and your team will be able to attend the event, even volunteer in the running of it, and see first-hand how supporting a great cause can make the world of difference in finding a cure
• Pro bono or in-kind support that will help make significant cost savings. Skilled staff can support and mentor CCIA staff in many areas and help develop the potential of our organisation.
If you are interested in becoming a corporate donor, contact our Corporate Partnerships Executive on (02) 9385 8467.
To donate online now, click here. If you would prefer to mail or fax your donation, please download our donation form. Alternatively, contact our Supporter Care Team on 1800 685 686 or email supportercare@ccia.org.au

Spotlight on a research funding partner... David Jones

Senior scientist Michelle Henderson receives $100,000 annually from retailer David Jones to sponsor her work on neuroblastoma. This is a partcularly vicious solid tumour in children with poor survival outcomes.
“I am thrilled to have the financial support of David Jones to enable me to contribute to CCIA’s experimental therapeutics program. With this funding, I can carry out vital research into designing more effective treatments for neuroblastoma, which will have a direct impact upon saving the lives of children with this cancer. Thanks to David Jones' continuing support, this research has progressed to a point where we have discovered important new factors when treating neuroblastoma.”
Michelle Henderson, senior scientist, CCIA